Changes In Health Services Use After Receipt Of Medications For Opioid Use Disorder In A Statewide Correctional System

被引:12
作者
Howell, Benjamin A. [1 ,2 ]
Martin, Rosemarie A. [3 ]
Lebeau, Rebecca [4 ]
Truong, Ashley Q. [5 ]
Wang, Emily A. [1 ]
Rich, Josiah D. [6 ,7 ]
Clarke, Jennifer G. [8 ]
机构
[1] Yale Sch Med, Sect Gen Internal Med, New Haven, CT 06510 USA
[2] Yale Sch Med, SEICHE Ctr, New Haven, CT 06510 USA
[3] Brown Univ, Sch Publ Hlth, Dept Behav & Social Sci, Providence, RI USA
[4] Rhode Isl Execut Off Hlth & Human Serv, Cranston, RI USA
[5] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA
[6] Brown Univ, Med & Epidemiol, Div Infect Dis, Providence, RI 02912 USA
[7] Miriam Hosp, Ctr Prisoner Hlth & Human Rights, Providence, RI 02906 USA
[8] Rhode Isl Dept Correct, Cranston, RI USA
关键词
ECONOMIC BURDEN; ASSISTED TREATMENT; UNITED-STATES; OVERDOSE; MORTALITY; RELEASE; COSTS; ABUSE; RISK;
D O I
10.1377/hlthaff.2020.02156
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
To decrease opioid overdose mortality, prisons and jails in the US are increasingly offering medications for opioid use disorder (OUD) to incarcerated people. It is unknown how receipt of these medications in a correctional setting affects health services use after release. In this article we analyze changes in postrelease health care use after the implementation of a statewide medications for OUD program in the unified jail and prison system of the Rhode Island Department of Corrections. Using Medicaid claims data, we examined individual health care use in the community before and after receipt of medications for OUD while incarcerated. We found that inpatient admissions did not change, emergency department visits decreased, and both nonacute outpatient services and pharmacy claims increased after people received medications for OUD while incarcerated. There was no change in total health care costs paid by Medicaid. Our findings provide evidence that people's use of health care services paid for by Medicaid did not increase after they started medications for OUD in correctional settings. Given the frequent interaction of people with OUD with the criminal justice system, offering evidence-based treatment of OUD in correctional settings is an important opportunity to initiate addiction treatment.
引用
收藏
页码:1304 / 1311
页数:8
相关论文
共 50 条
  • [21] Estimating the impact of wide scale uptake of screening and medications for opioid use disorder in US prisons and jails
    Macmadu, Alexandria
    Goedel, William C.
    Adams, Joella W.
    Brinkley-Rubinstein, Lauren
    Green, Traci C.
    Clarke, Jennifer G.
    Martin, Rosemarie A.
    Rich, Josiah D.
    Marshall, Brandon D. L.
    DRUG AND ALCOHOL DEPENDENCE, 2020, 208
  • [22] Opioid Use Disorder and Employee Work Presenteeism, Absences, and Health Care Costs
    Henke, Rachel Mosher
    Ellsworth, David
    Wier, Lauren
    Snowdon, Jane
    JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2020, 62 (05) : 344 - 349
  • [23] Opioid Use and Chronic Infections: The Value of Addressing the Syndemic in Correctional Settings Via Telemedicine Guidance and Broader Use of Long-Acting Medications
    Krsak, Martin
    Montague, Brian T.
    Trowbridge, Paul
    Johnson, Steven C.
    Binswanger, Ingrid A.
    JOURNAL OF INFECTIOUS DISEASES, 2020, 222 : S486 - S493
  • [24] Barriers and Facilitators to the Use of Medications for Opioid Use Disorder: a Rapid Review
    Mackey, Katherine
    Veazie, Stephanie
    Anderson, Johanna
    Bourne, Donald
    Peterson, Kim
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (SUPPL 3) : 954 - 963
  • [25] Addressing Racial And Ethnic Disparities In The Use Of Medications For Opioid Use Disorder
    Andraka-Christou, Barbara
    HEALTH AFFAIRS, 2021, 40 (06) : 920 - 927
  • [26] Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse
    Greiner, Miranda G.
    Shulman, Matisyahu
    Choo, Tse-Hwei
    Scodes, Jennifer
    Pavlicova, Martina
    Campbell, Aimee N. C.
    Novo, Patricia
    Fishman, Marc
    Lee, Joshua D.
    Rotrosen, John
    Nunes, Edward, V
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2021, 131
  • [27] Perspectives of substance use disorder counselors on the benefits and drawbacks of medications for opioid use disorder
    Cardamone, Nicholas C.
    Stewart, Rebecca E.
    Kampman, Kyle M.
    Marcus, Steven C.
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2025, 20 (01):
  • [28] Provider-directed marketing may increase prescribing of medications for opioid use disorder
    Thuy Nguyen
    Andraka-Christou, Barbara
    Simon, Kosali
    Bradford, W. David
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2019, 104 : 104 - 115
  • [29] Identifying risk of opioid use disorder for patients taking opioid medications with deep learning
    Dong, Xinyu
    Deng, Jianyuan
    Rashidian, Sina
    Abell-Hart, Kayley
    Hou, Wei
    Rosenthal, Richard N.
    Saltz, Mary
    Saltz, Joel H.
    Wang, Fusheng
    JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2021, 28 (08) : 1683 - 1693
  • [30] Barriers to Medications for Opioid Use Disorder Among Veterans Involved in the Legal System: a Qualitative Study
    Finlay, Andrea K.
    Morse, Erica
    Stimmel, Matthew
    Taylor, Emmeline
    Timko, Christine
    Harris, Alex H. S.
    Smelson, David
    Yu, Mengfei
    Blue-Howells, Jessica
    Binswanger, Ingrid A.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (09) : 2529 - 2536